Whole genome sequencing for somatic mutations in gtex
Ended Awarded Last action
- Contract number
- 75N92021F00001
- Awardee
-
The Broad Institute, Inc. UEI H5G9NWEFHXN4
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $951,700
Award facts
- Opportunity
-
- 75N92021R0039 Solicitation number
- Contract value 100% obligated
- $951,700.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,300 | |
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Original award | $954,000 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $951.7K delivery order to The Broad Institute, Inc. for whole genome sequencing to identify somatic mutations in the Genotype-Tissue Expression (GTEx) project. This contract, which includes a no-cost extension with an ultimate completion date of July 25, 2022, operates under a firm fixed-price model with no set-aside designation. The work will be performed in Bethesda, Maryland, and represents a continuation of specialized genomic research services that support the NHLBI's broader precision medicine and genomics research objectives.
This delivery order is issued under the Centralized Omics Resource (CORE) for Trans-Omics for Precision Medicine (TOPMed), a $500M indefinite delivery contract vehicle with NHLBI that enables large-scale genomic research initiatives. The Broad Institute, a collaborative non-profit research organization between MIT and Harvard, leverages its substantial expertise in genomic data generation, analysis, and management to support federal research programs. Through the TOPMed CORE contract, the Broad Institute provides comprehensive genomic sequencing and analytical services that advance understanding of the genetic basis of complex diseases and support the NHLBI's precision medicine mission.
Quick answers
Who was awarded contract 75N92021F00001?
75N92021F00001 was awarded to The Broad Institute, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 26, 2021.
How much is contract 75N92021F00001 worth?
The government has obligated $951,700 on 75N92021F00001.
Is contract 75N92021F00001 an order under another contract?
Yes. 75N92021F00001 is a delivery order under HHSN268201600034I, an indefinite delivery contract, on Centralized Omic REsource for TOPMed (CORE).
Was contract 75N92021F00001 competed?
The extent of competition for 75N92021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award